First National Bank of Omaha’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.9M Buy
27,553
+3,484
+14% +$1.67M 0.39% 63
2026
Q1
$11.6M Sell
24,069
-2,928
-11% -$1.59M 0.36% 70
2025
Q4
$15.7M Buy
26,997
+24,087
+828% +$13.6M 0.47% 46
2025
Q3
$1.41M Sell
2,910
-167
-5% -$77.7K 0.09% 209
2025
Q2
$1.25M Sell
3,077
-5,509
-64% -$2.3M 0.08% 214
2025
Q1
$4.27M Sell
8,586
-172
-2% -$93.2K 0.29% 101
2024
Q4
$4.56M Sell
8,758
-1,830
-17% -$1.01M 0.3% 95
2024
Q3
$6.55M Sell
10,588
-775
-7% -$459K 0.42% 74
2024
Q2
$6.28M Buy
11,363
+2,777
+32% +$1.59M 0.41% 78
2024
Q1
$4.27M Sell
8,586
-5,437
-39% -$3.05M 0.29% 101
2023
Q4
$7.44M Sell
14,023
-2,083
-13% -$1.01M 0.47% 71
2023
Q3
$8.15M Sell
16,106
-2,379
-13% -$1.27M 0.53% 55
2023
Q2
$9.64M Sell
18,485
-825
-4% -$445K 0.55% 53
2023
Q1
$11.1M Buy
19,310
+570
+3% +$321K 0.67% 38
2022
Q4
$10.3M Sell
18,740
-1,284
-6% -$680K 0.64% 48
2022
Q3
$10.2M Sell
20,024
-383
-2% -$214K 0.66% 43
2022
Q2
$11.1M Sell
20,407
-445
-2% -$245K 0.67% 43
2022
Q1
$12.3M Sell
20,852
-530
-2% -$304K 0.63% 47
2021
Q4
$14.3M Sell
21,382
-1,922
-8% -$1.2M 0.68% 37
2021
Q3
$13.3M Sell
23,304
-1,324
-5% -$727K 0.68% 37
2021
Q2
$11.2M Hold
24,628
0.59% 47
2021
Q1
$11.2M Buy
24,628
+2,617
+12% +$1.25M 0.59% 47
2020
Q4
$10.3M Sell
22,011
-2,958
-12% -$1.39M 0.56% 54
2020
Q3
$11M Sell
24,969
-33
-0.1% -$13.6K 0.69% 42
2020
Q2
$9.06M Buy
25,002
+334
+1% +$112K 0.61% 48
2020
Q1
$7M Sell
24,668
-620
-2% -$196K 0.55% 58
2019
Q4
$8.21M Sell
25,288
-4,625
-15% -$1.4M 0.5% 61
2019
Q3
$8.71M Sell
29,913
-411
-1% -$118K 0.56% 53
2019
Q2
$8.9M Sell
30,324
-6,494
-18% -$1.79M 0.58% 51
2019
Q1
$10.1M Sell
36,818
-120
-0.3% -$29.9K 0.69% 40
2018
Q4
$8.27M Sell
36,938
-1,349
-4% -$317K 0.63% 45
2018
Q3
$9.35M Sell
38,287
-650
-2% -$150K 0.52% 51
2018
Q2
$8.06M Buy
38,937
+521
+1% +$111K 0.47% 63
2018
Q1
$7.93M Sell
38,416
-730
-2% -$153K 0.47% 61
2017
Q4
$7.43M Sell
39,146
-1,090
-3% -$209K 0.43% 73
2017
Q3
$7.61M Sell
40,236
-1,929
-5% -$349K 0.47% 64
2017
Q2
$7.36M Sell
42,165
-4,032
-9% -$677K 0.46% 68
2017
Q1
$7.1M Sell
46,197
-2,898
-6% -$443K 0.43% 71
2016
Q4
$6.93M Sell
49,095
-851
-2% -$125K 0.43% 72
2016
Q3
$7.95M Sell
49,946
-545
-1% -$84K 0.58% 55
2016
Q2
$7.46M Buy
50,491
+6,739
+15% +$995K 0.55% 65
2016
Q1
$6.2M Sell
43,752
-375
-0.8% -$50.3K 0.46% 78
2015
Q4
$6.26K Buy
44,127
+699
+2% +$93.2K 0.45% 80
2015
Q3
$5.31K Sell
43,428
-10,492
-19% -$1.37M 0.39% 97
2015
Q2
$6.78K Hold
53,920
0.47% 69
2015
Q1
$6.78K Sell
53,920
-13,099
-20% -$1.69M 0.47% 69
2014
Q4
$8.4M Buy
67,019
+1,468
+2% +$179K 0.59% 50
2014
Q3
$7.98M Sell
65,551
-14,241
-18% -$1.73M 0.58% 48
2014
Q2
$9.41M Sell
79,792
-9,174
-10% -$1.08M 0.66% 32
2014
Q1
$10.7M Buy
88,966
+3,662
+4% +$435K 0.79% 29
2013
Q4
$9.5M Buy
85,304
+4,598
+6% +$457K 0.73% 28
2013
Q3
$7.44M Buy
80,706
+979
+1% +$88.5K 0.65% 38
2013
Q2
$6.75K Buy
+79,727
New +$6.64M 0.57% 46

Other funds holding TMO

First National Bank of Omaha's TMO Position: Q2 2026 in Review

First National Bank of Omaha increased its Thermo Fisher Scientific (TMO) stake by 14% in Q2 2026, buying an estimated $1.67M and bringing the position to 27,553 shares worth $13.9M. The position accounts for 0.39% of the portfolio, ranked #63.

First National Bank of Omaha first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.7M in Q4 2025. 1,615 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • First National Bank of Omaha held 27,553 shares of Thermo Fisher Scientific worth $13.9M as of Q2 2026.
  • First National Bank of Omaha bought 3,484 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.67M.
  • Thermo Fisher Scientific made up 0.39% of First National Bank of Omaha's portfolio in Q2 2026, its #63 holding.
  • First National Bank of Omaha first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • First National Bank of Omaha's Thermo Fisher Scientific position peaked at $15.7M in Q4 2025.
  • 1,615 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on First National Bank of Omaha's 13F filing for Q2 2026, filed 7 Aug 2026.